• where experts go to learn about FDA
  • Hyman Phelps McNamara

    • Silicon Valley Life Sciences DayAugust 7th, 2025

      Hyman, Phelps & McNamara, P.C. (HPM) is excited to announce a program that we are co-hosting with Freshfields geared toward early-stage biotech and medtech companies. This program will be a half-day, in-person event at Freshfields’ Silicon Valley office on Wednesday September 10, 2025, and will feature …

    • HP&M Welcomes Peter Dickos to the FirmJuly 24th, 2025

      Hyman, Phelps & McNamara, P.C. (“HP&M”) is pleased to announce that Peter “Pete” Dickos has joined the firm as Counsel. Pete brings nearly a decade of high-level government experience to HP&M’s Enforcement and Litigation practice, with a particular focus on complex regulatory and litigation challenges involving …

    • Upcoming Webinar on July 29: Avoiding Common Pitfalls During FDA InspectionsJuly 22nd, 2025

      As we have previously covered, FDA has long been on the receiving end of criticism about its lagging foreign inspection program.  The focus of the criticism has been that simply not enough foreign inspections are occurring at all and, when they do, they have historically …

    • ACI’s Annual Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products – West Coast EditionJuly 15th, 2025

      The American Conference Institute’s 3rd Annual West Coast Forum on Legal, Regulatory, and Compliance for Cosmetics & Personal Care Products is scheduled to take place from October 8-9, 2025 in Santa Monica, California.  The conference is the premier event on cosmetics and personal care products, where industry …

    • HPM’s Larry Houck Speaking at Opioid and Fentanyl Abuse Management SummitJuly 8th, 2025

      The diversion of controlled substances intended for patients by physicians, pharmacists, nurses and other trusted healthcare employees is a significant issue facing hospitals and healthcare facilities. Controlled substances are a necessary component of medical care for patients, and recent employee diversion incidents illustrate the continued vulnerability …

    • HP&M Seeks Experienced Regulatory ExpertJuly 2nd, 2025

      Hyman, Phelps & McNamara, P.C. (HP&M) seeks to add an experienced regulatory expert to our strong and busy team of non-attorney regulatory experts.  Our team assists clients with a wide variety of quality and manufacturing regulatory topics for drugs and biologics.  Types of matters include: Developing …

    • HP&M’s Sophia Gaulkin to Present at Life Sciences Pricing & Contracting USA SummitMay 16th, 2025

      Hyman, Phelps & McNamara, P.C. is pleased to announce that Sophia Gaulkin will be presenting and speaking on an expert panel at Informa Connect’s annual Life Sciences Pricing & Contracting USA Summit, which is being held virtually and in-person in Philadelphia on May 19-21. Ms. Gaulkin’s presentation, Product Price …

    • Access to HPM’s Free FDA Enforcement Webinar Now Available!May 1st, 2025

      Thanks to everyone who joined us today.  We are excited that you were able to join us for our discussion of enforcement under the new FDA.  We hope you enjoyed a lively conversation.  We appreciated all of the questions we received from the audience.  If …

    • Sell-Out Crowd for HPM’s Enforcement WebinarApril 29th, 2025

      We have reached maximum capacity for this Thursday’s webinar!  We are excited by the large interest in this topic, and are eager to share our insights about the latest changes impacting the FDA-regulated industry.  Registration is closed, but if you would like to be put …

    • ACI’s 23rd Advanced Summit on Life Sciences PatentsApril 8th, 2025

      Come together with leaders from the pharmaceutical, biotechnology, and diagnostic industries to unpack huge changes at the American Conference Institute’s 23rd Advanced Summit on Life Sciences Patents, which is scheduled to take place from May 19-20, 2025 at the New York Bar Association in New York, …

    • Hyman, Phelps & McNamara Enters its 45th Year Continuing to Expand its Capabilities to Meet Client NeedsApril 6th, 2025

      Hyman, Phelps & McNamara (HPM) marks its 45th Anniversary year by welcoming three accomplished professionals who reinforce the depth and breadth of the firm’s FDA and DEA practices. Naomi Lowy joins HPM as a Principal Drug Regulatory Expert after 18 years at the FDA’s Center for Drug …

    • ACI’s 21st Annual Paragraph IV DisputesMarch 13th, 2025

      The American Conference Institute’s 21st Annual Paragraph IV Disputes is scheduled to take place from April 29-30, 2025 at The Altman Building in New York, NY.  Widely recognized as the industry gold standard, the conference unites leaders from brand-name and generic drug companies, alongside federal judges, the …

    • HPM Director to Moderate at FDLI’s Food and Dietary Supplement Safety and Regulation ConferenceMarch 10th, 2025

      Hyman, Phelps & McNamara, P.C. Director Ricardo Carvajal will be moderating a session at the Food and Drug Law Institute’s (“FDLI’s”) upcoming 1-day conference on Food and Dietary Supplement Safety and Regulation, scheduled to take place on March 25. Join us for timely, in-depth discussions …

    • ACI’s 12th Annual Legal, Regulatory, and Compliance Forum on Cosmetics & Personal CareMarch 10th, 2025

      The American Conference Institute’s 12th Annual Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care is scheduled to take place from March 27-28, 2025, at the New York City Bar Association, New York, NY.  The conference is the premier event on cosmetics and personal care products, …

    • ACI’s 3rd Annual Forum on Advanced TherapeuticsMarch 3rd, 2025

      The American Conference Institute’s 3rd Annual Forum on Advanced Therapeutics is scheduled to take place from March 19-20, 2025, at the Seaport Hotel in Boston, MA.  The conference will bring together industry leaders to explore evolving market trends, regulatory frameworks, and intellectual property strategies shaping the …